You are here


Groundbreaking study in squamous cell lung cancer opens at more than a hundred and fifty new locationsThe Lung-MAP trial, a multi-drug, multi-sub-study, biomarker-driven clinical trial for patients... Read more
Novel drug and biologic applications with user fee goals in 2014’s second half cluster around infectious disease – notably hepatitis C, with three “breakthrough” drugs pending, antibiotics and... Read more
To the Editor:Darrow et al. (March 27 issue)1 present an incomplete and misleading review of the Food and Drug Administration (FDA) programs that are available to expedite drug development, review,... Read more
Friends of Cancer Research (Friends) is proud to join our many partner organizations in announcing the launch of the Lung Cancer Master Protocol (Lung-MAP) clinical trial. Lung-MAP is the product of... Read more
A bold new way to test cancer drugs started Monday in hundreds of hospitals around the U.S. In a medical version of speed dating, doctors will sort through multiple experimental drugs and match... Read more
A new way of evaluating tumors may soon help cancer patients identify the underlying genetic link to their disease - and the best possible treatment – all in a single test.Researchers are set to... Read more
Final guidance on expedited regulatory pathways suggests FDA is open to accelerated approval for some acute conditions; agency also provides examples outside of HIV/cancer arena where surrogate and... Read more
The nation will mark two important cancer milestones this year: the 1964 Surgeon General’s Report on Smoking and Health and the founding of the American Society of Clinical Oncology (ASCO), which... Read more
Chair & Founder Ellen Sigal Participates in Inaugural Roundtable  Executive Director Jeff Allen Testifies Before House Energy and Commerce CommitteeOn May 6, 2014, Friends Chair & Founder, Dr... Read more
Colorado, Missouri and Louisiana are poised to become the first states in the nation to give terminally ill patients the right to try experimental drugs without the blessing of the Food and Drug... Read more